New Metal-Catalyzed Reactions for the Synthesis of Bioactive Agents

用于合成生物活性剂的新金属催化反应

• 批准号: RGPIN-2017-04556
• 负责人: Evans, PAndrew
• 金额: $ 7.72万
• 依托单位: Queen's University
• 依托单位国家: 加拿大
• 项目类别: Discovery Grants Program - Individual
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=632824
• 关键词: New; Metal; Catalyzed; Reactions; Synthesis

The increasing cost of drug discovery because to the low success rate of clinical candidates progressing through the various phases of drug development (0.2%), has prompted serious analysis of the factors that contribute to the failure rate.

由于临床候选人在药物开发的不同阶段进展的成功率较低(0.2%)，药物发现的成本不断增加，这促使人们认真分析导致失败率的因素。